BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9613789)

  • 21. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous transplant for CML revisited.
    Daley GQ; Goldman JM
    Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T; Hawrylecka D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():62-6. PubMed ID: 10494185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
    Vinogradova OA; Savchenko VG; Neverova AL; Diachenko LV; Domracheva EV; Liubimova LS; Mendeleeva LP
    Ter Arkh; 2001; 73(7):26-34. PubMed ID: 11523405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF; Fan ZP; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1227-9, 1241. PubMed ID: 15567763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
    Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation.
    Kebriaei P; Winter JN; Laport GG; Le Beau MM; Dewald G; Larson RA
    Leuk Res; 2004 May; 28(5):537-40. PubMed ID: 15068908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient.
    Varadi G; Ackerstein A; Ben-Neriah S; Nagler A
    Bone Marrow Transplant; 1998 Jan; 21(1):93-6. PubMed ID: 9486502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
    Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
    Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic cryopreserved marrow transplantation in a patient with chronic myelogenous leukemia].
    Akatsuka Y; Takeshita T; Tsuzuki S; Suzuki R; Sugihara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1994 Mar; 35(3):304-8. PubMed ID: 8158854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
    McGlave PB; Arthur D; Miller WJ; Lasky L; Kersey J
    Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the polymerase chain reaction to monitor engraftment following allogeneic bone marrow transplantation.
    Chalmers EA; Sproul AM; Mills KI; Gibson BE; Burnett AK
    Bone Marrow Transplant; 1990 Dec; 6(6):399-403. PubMed ID: 2097008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
    Rowe JM; Rapoport AP; Ryan DH; Nilsson BI; Duerst RE; Packman CH; Abboud CN; DiPersio JF; Linder T; Wang N; Simonsson B; Liesveld JL
    Bone Marrow Transplant; 1999 Nov; 24(10):1057-63. PubMed ID: 10578155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
    Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM
    Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot study.
    Coutinho LH; Chang J; Brereton ML; Morgenstern GR; Scarffe JH; Harrison CJ; Yin JA; Darbyshire PJ; Burdach S; Dexter TM; Testa NG
    Bone Marrow Transplant; 1997 May; 19(10):969-76. PubMed ID: 9169640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
    Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
    Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.